A retrospective, single center, case series study of chronic HCV patients who treated with direct acting antivirals
Latest Information Update: 21 Oct 2020
At a glance
- Drugs Daclatasvir (Primary) ; Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 Oct 2020 New trial record
- 29 Aug 2020 Results assessing dermatological manifestations in the era of new direct acting antivirals, presented at The International Liver Congress 2020